AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 28th, 2010 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research
This Amendment No. 2 (this "Amendment") to the Securities Purchase Agreement dated June 8, 2009 (individually the SPA, and with this Amendment and one previous Amendment the "Agreement") is dated as of April 23, 2010, by and between Oxygen Biotherapeutics, Inc., a Delaware corporation (the "Company"), and JP SPC 1 Vatea, Segregated Portfolio (formerly Vatea Fund, Segregated Portfolio), a Cayman Islands company (the "Investor"). All capitalized terms used herein and not otherwise defined shall have the meaning ascribed to such terms in the SPA.
EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2010 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • California
THIS EMPLOYMENT AGREEMENT ("Agreement") is made effective as of February 1, 2009, between Oxygen Biotherapeutics, Inc., a Delaware corporation (hereinafter sometimes referred to as "OXBO" or the "Corporation") and Christian (AkA "Chris") J. Stern ("Stern").
